Effectiveness of the psychological and pharmacological treatment of catastrophisation in patients with fibromyalgia: a controlled randomised trial

Completed

• Conditions: Fibromyalgia; Musculoskeletal Diseases; Other soft tissue disorders, not elsewhere classified

• Registration Number: ISRCTN10804772
• Lead Sponsor: The Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-09-29
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

1. Aged 18 - 65 years, either sex
2. Able to understand and read Spanish
3. Fulfil criteria for primary fibromyalgia according to the American College of Rheumatology
4. No previous psychological treatment
5. No pharmacological treatment or acceptance to discontinue it two weeks before the onset of the study
6. Signed informed consent

Exclusion Criteria

1. Severe Axis I psychiatric disorder (dementia, schizophrenia, paranoid disorder, abuse of alcohol and/or drug disorders)
2. Severe Axis II disorder from the clinician viewpoint that prevents the patient from following the treatment protocol
3. Pregnancy or lactation
4. Refusal to participate

Study & Design

• Study Type: Interventional
• Study Design: Not specified